Literature DB >> 33387018

Tumor necrosis factor-alpha is associated with mineral bone disorder and growth impairment in children with chronic kidney disease.

Kelly Meza1, Sharmi Biswas1, Yuan-Shan Zhu2, Anuradha Gajjar1,3, Eduardo Perelstein1,3, Juhi Kumar1,3, Oleh Akchurin4,5.   

Abstract

BACKGROUND: Mineral and bone disorder (MBD) and growth impairment are common complications of pediatric chronic kidney disease (CKD). Chronic inflammation detrimentally affects bone health and statural growth in non-CKD settings, but the impact of inflammation on CKD-MBD and growth in pediatric CKD remains poorly understood. This study assessed associations between inflammatory cytokines with biomarkers of CKD-MBD and statural growth in pediatric CKD.
METHODS: This is a cross-sectional study of children with predialysis CKD stages II-V. Cytokines (IL-1b, IL-4, IL-6, IL-8, IL-10, IL-12, IL-13, TNF-α, interferon-γ), bone alkaline phosphatase (BAP), and procollagen type 1 N-terminal propeptide (P1NP) were measured at the same time as standard CKD-MBD biomarkers. Associations between cytokines, CKD-MBD biomarkers, and height z-score were assessed using linear regression analysis.
RESULTS: Among 63 children, 52.4% had stage 3 CKD, 76.2% non-glomerular CKD etiology, and 21% short stature. TNF-α was the only cytokine associated with parathyroid hormone (PTH) independent of glomerular filtration rate. After stratification by low, medium, and high TNF-α tertiles, significant differences in PTH, serum phosphorus, alkaline phosphatase, BAP, P1NP, and height z-score were found. In a multivariate analysis, TNF-α positively associated with phosphorus, PTH, and alkaline phosphatase and inversely associated with height z-score, independent of kidney function, age, sex, and active vitamin D analogue use.
CONCLUSIONS: TNF-α is positively associated with biomarkers of CKD-MBD and inversely associated with height z-score, indicating that inflammation likely contributes to the development of CKD-MBD and growth impairment in pediatric CKD. Prospective studies to definitively assess causative effects of inflammation on bone health and growth in children with CKD are warranted.

Entities:  

Keywords:  CKD-mineral and bone disorder; Chronic kidney disease; Inflammation; Pediatric; TNF-α

Mesh:

Substances:

Year:  2021        PMID: 33387018      PMCID: PMC8087625          DOI: 10.1007/s00467-020-04846-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.651


  45 in total

1.  FGF23 induces left ventricular hypertrophy.

Authors:  Christian Faul; Ansel P Amaral; Behzad Oskouei; Ming-Chang Hu; Alexis Sloan; Tamara Isakova; Orlando M Gutiérrez; Robier Aguillon-Prada; Joy Lincoln; Joshua M Hare; Peter Mundel; Azorides Morales; Julia Scialla; Michael Fischer; Elsayed Z Soliman; Jing Chen; Alan S Go; Sylvia E Rosas; Lisa Nessel; Raymond R Townsend; Harold I Feldman; Martin St John Sutton; Akinlolu Ojo; Crystal Gadegbeku; Giovana Seno Di Marco; Stefan Reuter; Dominik Kentrup; Klaus Tiemann; Marcus Brand; Joseph A Hill; Orson W Moe; Makoto Kuro-O; John W Kusek; Martin G Keane; Myles Wolf
Journal:  J Clin Invest       Date:  2011-10-10       Impact factor: 14.808

2.  Early skeletal and biochemical alterations in pediatric chronic kidney disease.

Authors:  Katherine Wesseling-Perry; Renata C Pereira; Chi-Hong Tseng; Robert Elashoff; Joshua J Zaritsky; Ora Yadin; Shobha Sahney; Barbara Gales; Harald Jüppner; Isidro B Salusky
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 8.237

3.  The bone and mineral disorder of children undergoing chronic peritoneal dialysis.

Authors:  Dagmara Borzych; Lesley Rees; Il Soo Ha; Annabelle Chua; Patricia G Valles; Maria Lipka; Pedro Zambrano; Thurid Ahlenstiel; Sevcan A Bakkaloglu; Ana P Spizzirri; Laura Lopez; Fatih Ozaltin; Nikoleta Printza; Pankaj Hari; Günter Klaus; Mustafa Bak; Andrea Vogel; Gema Ariceta; Hui Kim Yap; Bradley A Warady; Franz Schaefer
Journal:  Kidney Int       Date:  2010-09-01       Impact factor: 10.612

4.  US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Authors:  Rajiv Saran; Bruce Robinson; Kevin C Abbott; Jennifer Bragg-Gresham; Xiaoying Chen; Debbie Gipson; Haoyu Gu; Richard A Hirth; David Hutton; Yan Jin; Alissa Kapke; Vivian Kurtz; Yiting Li; Keith McCullough; Zubin Modi; Hal Morgenstern; Purna Mukhopadhyay; Jeffrey Pearson; Ronald Pisoni; Kaitlyn Repeck; Douglas E Schaubel; Ruth Shamraj; Diane Steffick; Megan Turf; Kenneth J Woodside; Jie Xiang; Maggie Yin; Xiaosong Zhang; Vahakn Shahinian
Journal:  Am J Kidney Dis       Date:  2019-11-05       Impact factor: 8.860

5.  Parathyroid hormone and growth in children with chronic renal failure.

Authors:  Simon C Waller; Deborah Ridout; Tom Cantor; Lesley Rees
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

Review 6.  Cardiovascular risk and mineral bone disorder in patients with chronic kidney disease.

Authors:  Hagen Staude; Susann Jeske; Karin Schmitz; Gert Warncke; Dagmar-Christiane Fischer
Journal:  Kidney Blood Press Res       Date:  2013-03-18       Impact factor: 2.687

7.  Fracture Burden and Risk Factors in Childhood CKD: Results from the CKiD Cohort Study.

Authors:  Michelle R Denburg; Juhi Kumar; Thomas Jemielita; Ellen R Brooks; Amy Skversky; Anthony A Portale; Isidro B Salusky; Bradley A Warady; Susan L Furth; Mary B Leonard
Journal:  J Am Soc Nephrol       Date:  2015-07-02       Impact factor: 10.121

8.  Disordered FGF23 and mineral metabolism in children with CKD.

Authors:  Anthony A Portale; Myles Wolf; Harald Jüppner; Shari Messinger; Juhi Kumar; Katherine Wesseling-Perry; George J Schwartz; Susan L Furth; Bradley A Warady; Isidro B Salusky
Journal:  Clin J Am Soc Nephrol       Date:  2013-12-05       Impact factor: 8.237

9.  Stature in children with chronic kidney disease: analysis of NAPRTCS database.

Authors:  Mouin G Seikaly; Nina Salhab; Debbie Gipson; Verna Yiu; Donald Stablein
Journal:  Pediatr Nephrol       Date:  2006-04-01       Impact factor: 3.714

Review 10.  Chronic kidney disease: mineral and bone disorder in children.

Authors:  Katherine Wesseling-Perry; Isidro B Salusky
Journal:  Semin Nephrol       Date:  2013-03       Impact factor: 5.299

View more
  4 in total

Review 1.  Bone Turnover Markers in Children: From Laboratory Challenges to Clinical Interpretation.

Authors:  Aurélie Ladang; Frank Rauch; Edgard Delvin; Etienne Cavalier
Journal:  Calcif Tissue Int       Date:  2022-03-04       Impact factor: 4.333

2.  Factors associated with 1-year changes in serum fibroblast growth factor 23 levels in pediatric patients with chronic kidney disease.

Authors:  Natsumi Yamamura-Miyazaki; Toshimi Michigami; Keiichi Ozono; Katsusuke Yamamoto; Yukiko Hasuike
Journal:  Clin Exp Nephrol       Date:  2022-05-25       Impact factor: 2.617

3.  Hemodiafiltration Is Associated With Reduced Inflammation and Increased Bone Formation Compared With Conventional Hemodialysis in Children: The HDF, Hearts and Heights (3H) Study.

Authors:  Dagmar-Christiane Fischer; Colette Smith; Francesca De Zan; Justine Bacchetta; Sevcan A Bakkaloglu; Ayse Agbas; Ali Anarat; Bilal Aoun; Varvara Askiti; Karolis Azukaitis; Aysun Bayazit; Ipek Kaplan Bulut; Nur Canpolat; Dagmara Borzych-Dużałka; Ali Duzova; Sandra Habbig; Saoussen Krid; Christoph Licht; Mieczyslaw Litwin; Lukasz Obrycki; Fabio Paglialonga; Anja Rahn; Bruno Ranchin; Charlotte Samaille; Mohan Shenoy; Manish D Sinha; Brankica Spasojevic; Constantinos J Stefanidis; Enrico Vidal; Alev Yilmaz; Michel Fischbach; Franz Schaefer; Claus Peter Schmitt; Rukshana Shroff
Journal:  Kidney Int Rep       Date:  2021-07-06

4.  Erythropoiesis-independent effects of iron in chronic kidney disease.

Authors:  Edwin Patino; Oleh Akchurin
Journal:  Pediatr Nephrol       Date:  2021-07-09       Impact factor: 3.651

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.